Stock Track | Bionano Genomics Soars 6.20% on HC Wainwright's Buy Rating and $10 Price Target

Stock Track04-09

Shares of Bionano Genomics (BNGO) surged 6.20% in pre-market trading on Wednesday, following a bullish initiation from HC Wainwright. The biotechnology company, which specializes in genome analysis solutions, caught investors' attention after receiving a favorable analyst rating.

HC Wainwright initiated coverage on Bionano Genomics with a "Buy" rating and set an ambitious price target of $10. This price target suggests significant upside potential from the stock's previous closing price, fueling investor enthusiasm. The positive analyst outlook appears to be the primary driver behind the stock's pre-market rally.

The new coverage adds to the overall positive sentiment surrounding Bionano Genomics. According to FactSet, the company now has an average rating of "overweight" from analysts, with a mean price target of $7. This latest development underscores growing optimism about Bionano's prospects in the genomics sector and its potential for future growth. As the market digests this new coverage, investors will be watching closely to see if the stock can maintain its momentum when regular trading begins.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1102080260?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-09 22:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102080260","market":"us","top_or_hot":-1,"title":"Stock Track | Bionano Genomics Soars 6.20% on HC Wainwright's Buy Rating and $10 Price Target","media":"Stock Track","content":"<p>Shares of Bionano Genomics (BNGO) surged 6.20% in pre-market trading on Wednesday, following a bullish initiation from HC Wainwright. The biotechnology company, which specializes in genome analysis solutions, caught investors' attention after receiving a favorable analyst rating.</p>\n\n<p>HC Wainwright initiated coverage on Bionano Genomics with a \"Buy\" rating and set an ambitious price target of $10. This price target suggests significant upside potential from the stock's previous closing price, fueling investor enthusiasm. The positive analyst outlook appears to be the primary driver behind the stock's pre-market rally.</p>\n\n<p>The new coverage adds to the overall positive sentiment surrounding Bionano Genomics. According to FactSet, the company now has an average rating of \"overweight\" from analysts, with a mean price target of $7. This latest development underscores growing optimism about Bionano's prospects in the genomics sector and its potential for future growth. As the market digests this new coverage, investors will be watching closely to see if the stock can maintain its momentum when regular trading begins.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Bionano Genomics Soars 6.20% on HC Wainwright's Buy Rating and $10 Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Bionano Genomics Soars 6.20% on HC Wainwright's Buy Rating and $10 Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-04-09 22:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Bionano Genomics (BNGO) surged 6.20% in pre-market trading on Wednesday, following a bullish initiation from HC Wainwright. The biotechnology company, which specializes in genome analysis solutions, caught investors' attention after receiving a favorable analyst rating.</p>\n\n<p>HC Wainwright initiated coverage on Bionano Genomics with a \"Buy\" rating and set an ambitious price target of $10. This price target suggests significant upside potential from the stock's previous closing price, fueling investor enthusiasm. The positive analyst outlook appears to be the primary driver behind the stock's pre-market rally.</p>\n\n<p>The new coverage adds to the overall positive sentiment surrounding Bionano Genomics. According to FactSet, the company now has an average rating of \"overweight\" from analysts, with a mean price target of $7. This latest development underscores growing optimism about Bionano's prospects in the genomics sector and its potential for future growth. As the market digests this new coverage, investors will be watching closely to see if the stock can maintain its momentum when regular trading begins.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNGO","symbol_name":"Bionano Genomics","start_time":0,"source_url":"","article_id":"1102080260","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102080260","pubTimestamp":1744210405,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Bionano Genomics  surged 6.20% in pre-market trading on Wednesday, following a bullish initiation from HC Wainwright. The biotechnology company, which specializes in genome analysis solutions, caught investors' attention after receiving a favorable analyst rating.HC Wainwright initiated coverage on Bionano Genomics with a \"Buy\" rating and set an ambitious price target of $10. This price target suggests significant upside potential from the stock's previous closing price, fueling invest","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BNGO":"Bionano Genomics"},"translate_title":"股票赛道Bionano Genomics因HC Wainwright给予买入评级和10美元目标价而飙升6.20%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNGO":1},"content_text":"Shares of Bionano Genomics (BNGO) surged 6.20% in pre-market trading on Wednesday, following a bullish initiation from HC Wainwright. The biotechnology company, which specializes in genome analysis solutions, caught investors' attention after receiving a favorable analyst rating.\nHC Wainwright initiated coverage on Bionano Genomics with a \"Buy\" rating and set an ambitious price target of $10. This price target suggests significant upside potential from the stock's previous closing price, fueling investor enthusiasm. The positive analyst outlook appears to be the primary driver behind the stock's pre-market rally.\nThe new coverage adds to the overall positive sentiment surrounding Bionano Genomics. According to FactSet, the company now has an average rating of \"overweight\" from analysts, with a mean price target of $7. This latest development underscores growing optimism about Bionano's prospects in the genomics sector and its potential for future growth. As the market digests this new coverage, investors will be watching closely to see if the stock can maintain its momentum when regular trading begins.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1102080260","isCrawlerRequest":true}